1. Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, and
2. Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany;
3. John von Neumann Institute for Computing, Jülich Supercomputing Centre, Institute for Complex Systems–Structural Biochemistry (ICS-6), Forschungszentrum Jülich GmbH, Jülich, Germany;
4. Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany;
5. Institute for Pharmaceutical and Medicinal Chemistry, PharmaCampus, Westphalian Wilhelms University, Münster, Germany;
6. Institute for Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany;
7. Institute of Complex Systems, Structural Biochemistry (ICS-6), Forschungszentrum Jülich GmbH, Jülich, Germany;
8. Hematology/Oncology, Internal Medicine II, Jena University Hospital, Jena, Germany;
9. Institute for Transplantation Diagnostics and Cell Therapeutics and
10. Department of Surgery (A), Heinrich Heine University Düsseldorf, Düsseldorf, Germany;
11. Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany;
12. Institute of Neuropathology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany;
13. Division of Pediatric Neuro-Oncogenomics, German Cancer Consortium, partner site University Hospital Düsseldorf, Düsseldorf, Germany;
14. Institute for Biochemical Plant Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; and
15. Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Leipzig University, Leipzig, Germany